AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.53 |
Market Cap | 188.04M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.39 |
PE Ratio (ttm) | -3.88 |
Forward PE | n/a |
Analyst | Hold |
Ask | 1.65 |
Volume | 490,740 |
Avg. Volume (20D) | 742,381 |
Open | 1.54 |
Previous Close | 1.51 |
Day's Range | 1.41 - 1.54 |
52-Week Range | 0.91 - 5.17 |
Beta | undefined |
About SKIN
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the co...
Analyst Forecast
According to 5 analyst ratings, the average rating for SKIN stock is "Hold." The 12-month stock price forecast is $1.88, which is an increase of 24.09% from the latest price.
Next Earnings Release
Analysts project revenue of $77.76M, reflecting a -19.67% YoY shrinking and earnings per share of -0.09, making a 28.57% increase YoY.
2 months ago · seekingalpha.com
The Beauty Health Company (SKIN) Q3 2024 Earnings Call TranscriptThe Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan...